Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-31

Clinical Trial Update: Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence

View source ↗

Summary

A recruiting clinical trial evaluating immunotolerance and immune profiling in the endometrial cancer tumor microenvironment to improve risk stratification for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Regina Elena Cancer Institute | Conditions: Endometrial Cancer | Status: RECRUITING